Licayan, Vilma .
HRN: 27-10-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/16/2025
06/16/2025
IVTT
4.5G
STAT
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes